Proteinuria, hematuria, hypertension, and decreased renal function in a patient with diabetes for 9 years (Q67601721)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1463000%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

title

Proteinuria, hematuria, hypertension, and decreased renal function in a patient with diabetes for 9 years (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1463000%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

author name string

R. A. Rodby

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1463000

29 September 2022

M. M. Schwartz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1463000

29 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1463000

29 September 2022

publication date

1 December 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1463000%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

15 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1463000%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1463000%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1463000%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

page(s)

658-667

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1463000%20AND%20SRC:MED&resulttype=core&format=json

C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control

15 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Microalbuminuria in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

The predictive value of microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Microalbuminuria in type I diabetic patients. Prevalence and clinical characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Diabetic nephropathy: urinary albumin or total protein?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Natural course and prognosis of juvenile diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

THE COURSE OF JUVENILE DIABETES TREATED WITH UNMEASURED DIET

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Hematuria and red cell casts in typical diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

The Development of Lesions in the Glomerular Basement Membrane and Mesangium After Transplantation of Normal Kidneys to Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Structural-functional relationships in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Diabetic fibrillosis. A report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Low-protein diets in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Differential regulation of protein kinase C and (Na,K)-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

NIH conference. Aldose reductase and complications of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Increased glycosylation of glomerular basement membrane collagen in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Biochemistry of glomerular basement membrane of the normal and diabetic human

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Clogging of the glomerular basement membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Role of nonenzymatic glycosylation in the development of the sequelae of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

The biochemistry of the complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Radioreceptor Assay for Advanced Glycosylation End Products

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

epsilon-Amino-lysine-bound glucose in human tissues obtained at autopsy. Increase in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Glycosylation of glomerular basement membrane in type 1 (insulin-dependent) diabetic children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Advanced nonenzymatic tissue glycosylation: cell-mediated interactions implicated in the complications associated with diabetes and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Effects of Nonenzymatic Glycosylation of Mesangial Matrix on Proliferation of Mesangial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Should there be an expanded role for kidney biopsy in the management of patients with type I diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom/Scandinavian Ponalrestat Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

The effect of the aldose reductase inhibitor, ponalrestat, on the progression of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970237-8

7 January 2021

10.1016/S0272-6386(12)70237-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1463000%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference